Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brüggemann is a privately held German specialty chemical company founded in 1868 and headquartered in Heilbronn. The group manufactures and supplies custom-tailored chemical products including polymer additives, reducing agents, zinc derivatives, ethanol and alcohol-based products, with operations in Germany, the United States, Hong Kong and Italy. Its business serves multiple industrial end markets such as plastics, paints and coatings, rubber, and pharma-related alcohol applications rather than developing therapeutic drugs. The company also operates BrüggemannAlcohol, which produces ethanol and related alcohol products meeting pharmaceutical and other regulated-use requirements, including GMP-certified operations in Heilbronn. Brüggemann positions itself as a niche-oriented, family-owned manufacturer with in-house R&D, application technology and production capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BrüggemannGruppe.